Practice Guideline for the Treatment of Patients With Obsessive-Compulsive Disorder

The PHQ-9: Validity of a brief depression severity measure

Kroenke, K., Spitzer, R. L., & Williams, J. B. W. (2001) · Journal of General Internal Medicine · doi:10.1046/j.1525-1497.2001.016009606.x · Cited by 44,910

The Yale-Brown Obsessive Compulsive Scale: I. Development, Use, and Reliability

Goodman, W. K. (1989) · Archives of General Psychiatry · doi:10.1001/archpsyc.1989.01810110048007 · Cited by 7,712

The PHQ-9: A New Depression Diagnostic and Severity Measure

Kroenke, K., & Spitzer, R. L. (2002) · Psychiatric Annals · doi:10.3928/0048-5713-20020901-06 · Cited by 5,898

Untitled work

(1962) · Medical Entomology and Zoology · Cited by 4,856

The Obsessive-Compulsive Inventory: Development and validation of a short version.

Foa, E. B., Huppert, J. D., Leiberg, S., Langner, R., Kichic, R., Hajcak, G., & Salkovskis, P. M. (2002) · Psychological Assessment · doi:10.1037/1040-3590.14.4.485 · Cited by 2,959

The Yale-Brown Obsessive Compulsive Scale: II. Validity

Goodman, W. K. (1989) · Archives of General Psychiatry · doi:10.1001/archpsyc.1989.01810110054008 · Cited by 2,799

The yale global tic severity scale: initial testing of a clinician-rated scale of tic severity

LECKMAN, J. F., RIDDLE, M. A., HARDIN, M. T., ORT, S. I., SWARTZ, K. L., STEVENSON, J., & COHEN, D. J. (1989) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-198907000-00015 · Cited by 2,146

Untitled work

(1993) · PubMed · Cited by 1,900

The measurement of disability

Sheehan, D. V., Harnett-Sheehan, K., & Raj, B. A. (1996) · International Clinical Psychopharmacology · doi:10.1097/00004850-199606003-00015 · Cited by 1,440

The Wender Utah Rating Scale: an aid in the retrospective diagnosis of childhood attention deficit hyperactivity disorder [published erratum appears in Am J Psychiatry 1993 Aug;150(8):1280]

(1993) · American Journal of Psychiatry · doi:10.1176/ajp.150.6.885 · Cited by 1,421

What Makes Deprescription of Psychotropic Drugs in Nursing Home Residents with Dementia so Challenging? A Qualitative Systematic Review of Barriers and Facilitators

Moth, A. E., Hølmkjær, P., Holm, A., Rozing, M. P., & Overbeck, G. (2021) · Drugs & Aging · doi:10.1007/s40266-021-00875-1 · Cited by 37

Obsessive-Compulsive Disorders

Mathews, C. (2021) · CONTINUUM Lifelong Learning in Neurology · doi:10.1212/con.0000000000001011 · Cited by 39

The relationship between obsessive-compulsive disorder and religious faith: Clinical characteristics and implications for treatment.

Himle, J. A., Chatters, L. M., Taylor, R. J., & Nguyen, A. W. (2011) · Psychology of Religion and Spirituality · doi:10.1037/a0023478 · Cited by 37

Different Views of Anxiety Disorders

Selek, S. (2011) · InTech eBooks · doi:10.5772/1022 · Cited by 39

Nationwide study of antipsychotic use among community-dwelling persons with Alzheimer's disease in Finland

Laitinen, M.-L., Bell, J. S., Lavikainen, P., Lönnroos, E., Sulkava, R. O., & Hartikainen, S. A. (2011) · International Psychogeriatrics · doi:10.1017/s1041610211001621 · Cited by 36

A Randomized, Controlled Trial of Cognitive-Behavioral Therapy for Augmenting Pharmacotherapy in Obsessive-Compulsive Disorder

Simpson, H. B., Foa, E. B., Liebowitz, M. R., Ledley, D. R., Huppert, J. D., Cahill, S. P., Vermes, D., Schmidt, A. B., Hembree, E. A., Franklin, M. E., et al. (2010) · FOCUS The Journal of Lifelong Learning in Psychiatry · doi:10.1176/foc.8.4.foc614 · Cited by 36

Teaching Caregivers of Persons with Dementia to Address Pain

Kunik, M. E., Snow, A. L., WILSON, N. L., Amspoker, A. B., Sansgiry, S., Morgan, R. O., Ying, J., Hersch, G. I., & Stanley, M. A. (2016) · American Journal of Geriatric Psychiatry · doi:10.1016/j.jagp.2016.04.009 · Cited by 36

Efficacy and Safety of Analgesic Treatment for Depression in People with Advanced Dementia: Randomised, Multicentre, Double-Blind, Placebo-Controlled Trial (DEP.PAIN.DEM)

Erdal, A., Flo, E., Aarsland, D., Ballard, C. G., Daltveit, D. S., & Husebo, B. S. (2018) · Drugs & Aging · doi:10.1007/s40266-018-0546-2 · Cited by 40

Disruption of prepulse inhibition is associated with compulsive behavior severity and nucleus accumbens dopamine receptor changes in Sapap3 knockout mice

Manning, E. E., Wang, A. Y., Saikali, L. M., Winner, A. S., & Ahmari, S. E. (2021) · Scientific Reports · doi:10.1038/s41598-021-88769-5 · Cited by 37

Factors Associated With Behavioral and Psychological Symptoms of Dementia: Prospective Observational Study Using Actigraphy

Cho, E., Kim, S., Hwang, S., Kwon, E., Heo, S., Lee, J. H., Ye, B. S., & Kang, B. (2021) · Journal of Medical Internet Research · doi:10.2196/29001 · Cited by 42

Better than treated as usual: Transcranial magnetic stimulation augmentation in selective serotonin reuptake inhibitor-refractory obsessive–compulsive disorder, mini-review and pilot open-label trial

Pallanti, S., Marras, A. M., Salerno, L., Makris, N., & Hollander, E. (2016) · Journal of Psychopharmacology · doi:10.1177/0269881116628427 · Cited by 36

Cost-effectiveness of cerebrospinal biomarkers for the diagnosis of Alzheimer’s disease

Lee, S. A. W., Sposato, L. A., Hachinski, V., & Cipriano, L. E. (2017) · Alzheimer s Research & Therapy · doi:10.1186/s13195-017-0243-0 · Cited by 38

An integrative model for understanding obsessive-compulsive disorder: merging cognitive behavioral theory with insights from clinical neuroscience

Kalanthroff, E., & Wheaton, M. G. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11247379 · Cited by 35

CBT for pharmacotherapy non-remitters—a systematic review of a next-step strategy

Rodrigues, H., Figueira, I., Gonçalves, R., Mendlowicz, M., Macedo, T., & Ventura, P. (2011) · Journal of Affective Disorders · doi:10.1016/j.jad.2010.08.025 · Cited by 35

Body dysmorphic disorder

Rück, C., Mataix-Cols, D., Feusner, J. D., Shavitt, R. G., Veale, D., Krebs, G., & Fernández de la Cruz, L. (2024) · Nature Reviews Disease Primers · doi:10.1038/s41572-024-00577-z · Cited by 35

Interoception and Obsessive-Compulsive Disorder: A Review of Current Evidence and Future Directions

Bragdon, L. B., Eng, G. K., Belanger, A., Collins, K. A., & Stern, E. R. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.686482 · Cited by 38

Memantine for autism spectrum disorder

Brignell, A., Marraffa, C., Williams, K. J., & May, T. (2022) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd013845.pub2 · Cited by 36

Evaluating the efficacy and safety of Alzheimer’s disease drugs: A meta-analysis and systematic review

Chen, Y., Lai, M., & Tao, M. (2024) · Medicine · doi:10.1097/md.0000000000037799 · Cited by 36

Virtual reality exposure for OCD: Is it feasible? [Exposición mediante realidad virtual para el TOC: ¿Es factible?]

Belloch, A., Cabedo, E., Carrió, C., Lozano-Quilis, J. A., Gil‐Gómez, J., & Gil-Gómez, H. (2014) · Revista de Psicopatología y Psicología Clínica · doi:10.5944/rppc.vol.19.num.1.2014.12981 · Cited by 35

Practical Diagnosis and Management of Dementia Due to Alzheimer’s Disease in the Primary Care Setting

Geldmacher, D., & Kerwin, D. R. (2013) · The Primary Care Companion For CNS Disorders · doi:10.4088/pcc.12r01474 · Cited by 35

Cognitive and psychiatric effects of vitamin B12 replacement in dementia with low serum B12 levels: a nursing home study

van Dyck, C. H., Lyness, J. M., Rohrbaugh, R. M., & Siegal, A. P. (2008) · International Psychogeriatrics · doi:10.1017/s1041610208007904 · Cited by 35

The costs of distraction: The effect of distraction during repeated picture processing on the LPP

Paul, S., Kathmann, N., & Riesel, A. (2016) · Biological Psychology · doi:10.1016/j.biopsycho.2016.04.002 · Cited by 35

Abnormalities of white matter microstructure in unmedicated patients with obsessive–compulsive disorder: Changes after cognitive behavioral therapy

Zhong, Z., Yang, X., Cao, R., Li, P., Li, Z., Lv, L., & Zhang, D. (2019) · Brain and Behavior · doi:10.1002/brb3.1201 · Cited by 37

Deep brain stimulation in the treatment of obsessive-compulsive disorder: current perspectives

Tastevin, M., Spatola, G., Régis, J. M., Lançon, C., & Richieri, R. M. (2019) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s178207 · Cited by 36

Application of attentional bias modification training to modulate hyperactive error-monitoring in OCD

Klawohn, J., Hajcak, G., Amir, N., Kathmann, N., & Riesel, A. (2020) · International Journal of Psychophysiology · doi:10.1016/j.ijpsycho.2020.07.005 · Cited by 38

Treatment‐resistant Obsessive‐compulsive Disorder in Young People: Assessment and Treatment Strategies

Krebs, G., & Heyman, I. (2009) · Child and Adolescent Mental Health · doi:10.1111/j.1475-3588.2009.00548.x · Cited by 36

Drug persistency of cholinesterase inhibitors for patients with dementia of Alzheimer type in Korea

Ahn, S.-H., Choi, N., Kim, Y., Seong, J.-M., Shin, J., Jung, S.-Y., & Park, B. (2014) · Archives of Pharmacal Research · doi:10.1007/s12272-014-0500-8 · Cited by 35

Hospital discharge processes involving older adults living with dementia: An integrated literature review

Stockwell‐Smith, G., Moyle, W., Marshall, A. P., Argo, A., Brown, L., Howe, S., Layton, K., Naidoo, O., Santoso, Y., Soleil‐Moudiky‐Joh, E., et al. (2018) · Journal of Clinical Nursing · doi:10.1111/jocn.14144 · Cited by 35

Six-Month Outcomes From a Randomized Trial Augmenting Serotonin Reuptake Inhibitors With Exposure and Response Prevention or Risperidone in Adults With Obsessive-Compulsive Disorder

Foa, E. B., Simpson, H. B., Rosenfield, D., Liebowitz, M. R., Cahill, S. P., Huppert, J. D., Bender Jr, J., McLean, C. P., Maher, M. J., Campeas, R., et al. (2015) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.14m09044 · Cited by 34

Assistive devices caregivers use and find helpful to manage problem behaviors of dementia

Gitlin, L. N., Winter, L., & Dennis, M. P. (2010) · Gerontechnology · doi:10.4017/gt.2010.09.03.006.00 · Cited by 36

Cognitive Mediation of Symptom Change in Exposure and Response Prevention for Obsessive-Compulsive Disorder

Su, Y., Carpenter, J. K., Zandberg, L. J., Simpson, H. B., & Foa, E. B. (2016) · Behavior Therapy · doi:10.1016/j.beth.2016.03.003 · Cited by 34

Impact of methamphetamine precursor chemical legislation, a suppression policy, on the demand for drug treatment

Cunningham, J. K., & Liu, L. (2008) · Social Science & Medicine · doi:10.1016/j.socscimed.2007.12.006 · Cited by 34

DNA-repair in mild cognitive impairment and Alzheimer's disease

Bucholtz, N., & Demuth, I. (2013) · DNA Repair · doi:10.1016/j.dnarep.2013.07.005 · Cited by 34

Making Sense(s) in Dementia

Cruz, J., Marques, A. S. P. D. D., Barbosa, A., de Figueiredo, D. M. P., & de Sousa, L. X. M. (2013) · American Journal of Alzheimer s Disease & Other Dementias® · doi:10.1177/1533317512473194 · Cited by 34

Feasibility of the Tailored Activity Program for Hospitalized (TAP-H) Patients With Behavioral Symptoms

Gitlin, L. N., Marx, K., Alonzi, D., Kvedar, T., Moody, J., Trahan, M. A., & Haitsma, K. S. V. (2016) · The Gerontologist · doi:10.1093/geront/gnw052 · Cited by 36

Pharmacological Treatment of Behavioral and Psychological Symptoms of Dementia (BPSD) in Nursing Homes: Development of Practice Recommendations in a Swiss Canton

Locca, J.-F., Büla, C., Zumbach, S., & Bugnon, O. (2008) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2008.04.003 · Cited by 36

People with dementia in long-term care facilities: an exploratory study of their activities and participation

Rocha, V., Marques, A. S. P. D. D., Pinto, M., de Sousa, L. X. M., & de Figueiredo, D. M. P. (2013) · Disability and Rehabilitation · doi:10.3109/09638288.2012.742677 · Cited by 36

Oral N-acetylcysteine in the treatment of obsessive-compulsive disorder: A systematic review of the clinical evidence

Couto, J. P., & Moreira, R. (2018) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2018.06.005 · Cited by 34

Abnormal spontaneous neural activity as a potential predictor of early treatment response in patients with obsessive–compulsive disorder

Yan, H., Shan, X., Li, H., Liu, F., & Guo, W. (2022) · Journal of Affective Disorders · doi:10.1016/j.jad.2022.04.125 · Cited by 33

Predictive value of familiality, stressful life events and gender on the course of obsessive-compulsive disorder

Goldberg, X., Soriano‐Mas, C., Alonso, P., Segalàs, C., Real, E., López‐Solà, C., Subirà, M., Via, E., Jiménez‐Múrcia, S., Menchón, J. M., et al. (2015) · Journal of Affective Disorders · doi:10.1016/j.jad.2015.06.047 · Cited by 33

Can early improvement be an indicator of treatment response in obsessive-compulsive disorder? Implications for early-treatment decision-making

Costa, D. L. D. C., Shavitt, R. G., Cesar, R. C., Joaquim, M. A., Borcato, S., Valério, C., Miguel, E. C., & Diniz, J. B. (2013) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2013.07.006 · Cited by 33

Good News for Dementia Care: Caregiver Interventions Reduce Behavioral Symptoms in People With Dementia and Family Distress

Gitlin, L. N. (2012) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2012.12060774 · Cited by 36

Predictors of medium and long-term outcome following capsulotomy for obsessive-compulsive disorder: one site may not fit all

Rück, C., Larsson, K. J., & Mataix-Cols, D. (2012) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2011.11.003 · Cited by 32

Beyond symptom improvement: transdiagnostic and disorder‐specific ways to assess functional and quality of life outcomes across mental disorders in adults

Correll, C. U., Cortese, S., Solmi, M., Boldrini, T., Demyttenaere, K., Domschke, K., Fusar‐Poli, P., Gorwood, P. A. P. M., Harvey, P. D., Keefe, R. S. E., et al. (2025) · World Psychiatry · doi:10.1002/wps.21338 · Cited by 33

Diagnosis and Treatment of a Patient With Both Psychotic and Obsessive-Compulsive Symptoms

Rodríguez, C. I., Corcoran, C. M., & Simpson, H. B. (2010) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2009.09070997 · Cited by 32

The Incidence of Benzodiazepine and Related Drug Use in Persons with and without Alzheimer’s Disease

Saarelainen, L., Taipale, H. T., Koponen, M., Tanskanen, A. J., Tolppanen, A., Tiihonen, J., & Hartikainen, S. A. (2015) · Journal of Alzheimer s Disease · doi:10.3233/jad-150630 · Cited by 32

Genetic susceptibility in obsessive-compulsive disorder

Fernandez, T. V., Leckman, J. F., & Pittenger, C. (2018) · Handbook of clinical neurology · doi:10.1016/b978-0-444-64076-5.00049-1 · Cited by 34

From Treatment Response to Recovery: A Realistic Goal in OCD

Burchi, E., Hollander, E., & Pallanti, S. (2018) · The International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyy079 · Cited by 32

Antipsychotic augmentation in the treatment of obsessive-compulsive disorder

Jaisoorya, T. S., & Thamby, A. (2019) · Indian Journal of Psychiatry · doi:10.4103/psychiatry.indianjpsychiatry_519_18 · Cited by 32

What Is the Impact of COVID-19 Pandemic on Patients with Pre-Existing Mood or Anxiety Disorder? An Observational Prospective Study

Tundo, A., Betrò, S., & Necci, R. (2021) · Medicina · doi:10.3390/medicina57040304 · Cited by 33

Emerging insights into the role of albumin with plasma exchange in Alzheimer’s disease management

Costa, M., & Páez, A. (2021) · Transfusion and Apheresis Science · doi:10.1016/j.transci.2021.103164 · Cited by 32

Effects of a Motor and Multisensory-Based Approach on Residents with Moderate-to-Severe Dementia

Cruz, J., Marques, A. S. P. D. D., Barbosa, A., de Figueiredo, D. M. P., & de Sousa, L. X. M. (2011) · American Journal of Alzheimer s Disease & Other Dementias® · doi:10.1177/1533317511411177 · Cited by 32

Galantamine-ER for the treatment of mild-to-moderate Alzheimer’s disease

Seltzer, B. (2009) · Clinical Interventions in Aging · doi:10.2147/cia.s4819 · Cited by 32

Cognitive-behavioural therapy for obsessive-compulsive disorder co-occurring with psychosis: Systematic review of evidence

Tundo, A., & Necci, R. (2016) · World Journal of Psychiatry · doi:10.5498/wjp.v6.i4.449 · Cited by 32

Preventing aggression in persons with dementia.

Nguyen, V., Love, A. R., & Kunik, M. E. (2008) · PubMed · Cited by 32

Agreement on Diagnosis Among Patients, Companions, and Professionals After a Dementia Evaluation

Zaleta, A. K., Carpenter, B. D., Porensky, E. K., Xiong, C., & Morris, J. C. (2012) · Alzheimer Disease & Associated Disorders · doi:10.1097/wad.0b013e3182351c04 · Cited by 31

Cognitive-Behavioral Therapy for Obsessive-Compulsive Disorder as a Comorbidity with Schizophrenia or Schizoaffective Disorder

Tundo, A., Salvati, L., Spigno, D. D., Cieri, L., Parena, A., Necci, R., & Sciortino, S. (2011) · Psychotherapy and Psychosomatics · doi:10.1159/000329455 · Cited by 31

Restriction of Access to Deep Brain Stimulation for Refractory OCD: Failure to Apply the Federal Parity Act

Davis, R. A., Giordano, J. J., Hufford, D. B., Sheth, S. A., Warnke, P. C., Widge, A. S., Richardson, R. M., Rosenow, J. M., Rossi, P. J., Storch, E. A., et al. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.706181 · Cited by 31

Ketamine increases activity of a fronto-striatal projection that regulates compulsive behavior in SAPAP3 knockout mice

Davis, G. L., Minerva, A. R., Lario, A., Simmler, L. D., Rodríguez, C. I., & Gunaydin, L. A. (2021) · Nature Communications · doi:10.1038/s41467-021-26247-2 · Cited by 35

Memantine augmentation of sertraline in the treatment of symptoms and executive function among patients with obsessive-compulsive disorder: A double-blind placebo-controlled, randomized clinical trial

Askari, S., Mokhtari, S., Shariat, S. V., Shariati, B., Yarahmadi, M., & Shalbafan, M. (2022) · BMC Psychiatry · doi:10.1186/s12888-021-03642-z · Cited by 32

Stepped care for obsessive-compulsive disorder: An open trial

Gilliam, C. M., Diefenbach, G. J., Whiting, S. E., & Tolin, D. F. (2010) · Behaviour Research and Therapy · doi:10.1016/j.brat.2010.07.010 · Cited by 31

Alternative Drug Therapies for Dementia

Howland, R. H. (2011) · Journal of Psychosocial Nursing and Mental Health Services · doi:10.3928/02793695-20110407-03 · Cited by 31

Use of antidepressants among community-dwelling persons with Alzheimer's disease: a nationwide register-based study

Laitinen, M.-L., Lönnroos, E., Bell, J. S., Lavikainen, P., Sulkava, R. O., & Hartikainen, S. A. (2014) · International Psychogeriatrics · doi:10.1017/s1041610214002427 · Cited by 34

Assessment and management of patients with cognitive impairment and dementia in primary care

Belmin, J., Min, L. C., Roth, C. P., Reuben, D. B., & Wenger, N. S. (2012) · The journal of nutrition health & aging · doi:10.1007/s12603-012-0026-z · Cited by 31

Change in obsessive beliefs as predictor and mediator of symptom change during treatment of obsessive-compulsive disorder – a process-outcome study

Diedrich, A., Sckopke, P., Schwartz, C., Schlegl, S., Osen, B., Stierle, C. M. G., & Voderholzer, U. (2016) · BMC Psychiatry · doi:10.1186/s12888-016-0914-6 · Cited by 33

Identification and Treatment of Peripartum Anxiety Disorders

Williams, K. E., & Koleva, H. K. (2018) · Obstetrics and Gynecology Clinics of North America · doi:10.1016/j.ogc.2018.04.001 · Cited by 33

HOW IMPORTANT IS THE THERAPEUTIC ALLIANCE IN TREATING OBSESSIVE-COMPULSIVE DISORDER WITH EXPOSURE AND RESPONSE PREVENTION? AN EMPIRICAL REPORT.

Wheaton, M. G., Huppert, J. D., Foa, E. B., & Simpson, H. B. (2016) · PubMed · Cited by 31

Task-based fMRI predicts response and remission to exposure therapy in obsessive-compulsive disorder

Pagliaccio, D., Middleton, R., Hezel, D., Steinman, S., Snorrason, I., Gershkovich, M., Campeas, R., Pinto, A., Van Meter, P., Simpson, H. B., et al. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1909199116 · Cited by 30

Design and rationale for a randomized controlled trial testing the efficacy of aerobic exercise for patients with obsessive-compulsive disorder

Abrantes, A. M., McLaughlin, N. C. R., Greenberg, B. D., Strong, D. R., Riebe, D. A., Mancebo, M. C., Rasmussen, S. A., Desaulniers, J. A., & Brown, R. A. (2012) · Mental health and physical activity · doi:10.1016/j.mhpa.2012.06.002 · Cited by 31

Ablative neurosurgery and deep brain stimulation for obsessive-compulsive disorder

Arumugham, S. S., Balachander, S., & Srinivas, D. (2019) · Indian Journal of Psychiatry · doi:10.4103/psychiatry.indianjpsychiatry_523_18 · Cited by 31

New insights and perspectives on the genetics of obsessive-compulsive disorder

Zai, G. C., Barta, C., Cath, D. C., Eapen, V., GELLER, D. A., & Grünblatt, E. (2019) · Psychiatric Genetics · doi:10.1097/ypg.0000000000000230 · Cited by 32

Are 5‐HT3antagonists effective in obsessive–compulsive disorder? A systematic review of literature

Serata, D., Kotzalidis, G. D., Rapinesi, C., Janiri, D., Pietro, S. D., Callovini, G., Piacentino, D., Gasperoni, C., Brugnoli, R., Ferri, V. R., et al. (2015) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.2461 · Cited by 30

How resistant is ‘treatment‐resistant’ obsessive‐compulsive disorder in youth?

Krebs, G., Isomura, K., Lang, K., Jassi, A. D., Heyman, I., Diamond, H., Advani, J., Turner, C. M., & Mataix‐Cols, D. (2014) · British Journal of Clinical Psychology · doi:10.1111/bjc.12061 · Cited by 33

The process of family-centered counseling for caregivers of persons with dementia: barriers, facilitators and benefits

Vernooij-Dassen, M. J. F. J., Joling, K. J., van Hout, H. P. J., & Mittelman, M. S. (2010) · International Psychogeriatrics · doi:10.1017/s1041610210000050 · Cited by 30

Obsessive compulsive and related disorders: comparing DSM-5 and ICD-11

Marras, A. M., Fineberg, N. A., & Pallanti, S. (2016) · CNS Spectrums · doi:10.1017/s1092852916000110 · Cited by 34

Obsessive-compulsive Disorder with Comorbid Bipolar Disorders: Clinical Features and Treatment Implications

Mucci, F., Toni, C., Favaretto, E., Vannucchi, G., Marazziti, D., & Perugi, G. (2019) · Current Medicinal Chemistry · doi:10.2174/0929867324666171108145127 · Cited by 31

The effectiveness of exposure and response prevention combined with pharmacotherapy for obsessive-compulsive disorder: A systematic review and meta-analysis

Mao, L., Hu, M., Luo, L., Wu, Y., Lu, Z., & Zou, J. (2022) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2022.973838 · Cited by 29

Safety, tolerability, and clinical and neural effects of single-dose psilocybin in obsessive-compulsive disorder: Protocol for a randomized, double-blind, placebo-controlled, non-crossover trial

Ching, T. H. W., Grazioplene, R., Bohner, C., Kichuk, S. A., DePalmer, G., D’Amico, E., Eilbott, J., Jankovsky, A., Burke, M., Hokanson, J., et al. (2023) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2023.1178529 · Cited by 29

Quality of psychopharmacological medication use in nursing home residents

Simoni, J. M., Wei, Y. J., Luong, M., Franey, C. S., HUANG, T.-Y. J., Rattinger, G. B., Zuckerman, I. H., Brandt, N., & Lucas, J. A. (2013) · Research in Social and Administrative Pharmacy · doi:10.1016/j.sapharm.2013.10.003 · Cited by 29

Treatment of obsessive-compulsive disorders (OCD) and obsessive-compulsive-related disorders (OCRD)

Krzyszkowiak, W., Kuleta-Krzyszkowiak, M., & Krzanowska, E. (2019) · Psychiatria Polska · doi:10.12740/pp/105130 · Cited by 28

Cognitive‐affective drivers of fixation in threat assessment

Meloy, J. R., & Rahman, T. (2020) · Behavioral Sciences & the Law · doi:10.1002/bsl.2486 · Cited by 35

Transcriptome alterations are enriched for synapse-associated genes in the striatum of subjects with obsessive-compulsive disorder

Piantadosi, S. C., McClain, L. L., Klei, L., Wang, J., Chamberlain, B. L., Springer, S. A., Lewis, D. A., Devlin, B., & Ahmari, S. E. (2021) · Translational Psychiatry · doi:10.1038/s41398-021-01290-1 · Cited by 30

Treatment Practices of Mild Cognitive Impairment in California Alzheimer's Disease Centers

Weinstein, A. M., Barton, C., Ross, L., Kramer, J. H., & Yaffe, K. S. (2009) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2009.02200.x · Cited by 29

A case-control study of sleep disturbances in pediatric obsessive-compulsive disorder

Jaspers‐Fayer, F., Lin, S. Y., Belschner, L., Mah, J. W. T., Chan, E., Bleakley, C., Ellwyn, R., Simpson, A., McKenney, K. S., & Stewart, S. E. (2018) · Journal of Anxiety Disorders · doi:10.1016/j.janxdis.2018.02.001 · Cited by 29

The Expanding Cognitive-Behavioural Therapy Treatment Umbrella for the Anxiety Disorders: Disorder-Specific and Transdiagnostic Approaches

Rector, N. A., Man, V., & Lerman, B. (2014) · The Canadian Journal of Psychiatry · doi:10.1177/070674371405900603 · Cited by 28

Change in agitation in Alzheimer's disease in the placebo arm of a nine-week controlled trial

Rosenberg, P. B., Drye, L. T., Porsteinsson, A. P., Pollock, B. G., Devanand, D. P., Frangakis, C., Ismail, Z., Marano, C., Meinert, C. L., Mintzer, J. E., et al. (2015) · International Psychogeriatrics · doi:10.1017/s1041610215001106 · Cited by 28

Predictors of response to cognitive behavioural therapy (CBT) for individuals with obsessive-compulsive disorder (OCD): a systematic review

McDonald, S., Melkonian, M., Karin, E., Dear, B. F., Titov, N., & Wootton, B. M. (2023) · Behavioural and Cognitive Psychotherapy · doi:10.1017/s1352465823000103 · Cited by 28

Outcomes of Cognitive Behaviour Therapy for Obsessive Compulsive Disorder in a Clinical Setting: A 10‐Year Experience from a Specialist OCD Service for Children and Adolescents

Nakatani, E., Mataix‐Cols, D., Micali, N., Turner, C. M., & Heyman, I. (2008) · Child and Adolescent Mental Health · doi:10.1111/j.1475-3588.2008.00509.x · Cited by 28

Living with incontinence: The experience of people with dementia

Cole, L., & Drennan, V. M. (2017) · Dementia · doi:10.1177/1471301217731171 · Cited by 28

Steady-State Pharmacokinetics of Rivastigmine in Patients with Mild to Moderate Alzheimer’s Disease Not Affected by Co-Administration of Memantine

Shua‐Haim, J. R., Smith, J. M., Picard, F., Sedek, G., Athalye, S. N., Pommier, F., & Lefèvre, G. Y. (2008) · Clinical Drug Investigation · doi:10.2165/00044011-200828060-00004 · Cited by 28

Mortality risk in current and new antipsychotic Alzheimer's disease users: Large scale Japanese study

Arai, H., Nakamura, Y., Taguchi, M., Kobayashi, H., Yamauchi, K., Schneider, L. S. S., & J‐CATIA Study Group (2016) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2016.03.006 · Cited by 30

Cognitive remediation therapy (CRT) as a treatment enhancer of eating disorders and obsessive compulsive disorders: study protocol for a randomized controlled trial

van Passel, B., Danner, U. N., Dingemans, A. E., van Furth, E. F., Sternheim, L. C., Elburg, A. A. V., van Minnen, A., van den Hout, M., Hendriks, G., & Cath, D. C. (2016) · BMC Psychiatry · doi:10.1186/s12888-016-1109-x · Cited by 29

Citalopram Ameliorates Impairments in Spatial Memory and Synaptic Plasticity in Female 3xTgAD Mice

Zhang, W., Junhong, G., Niu, X., Jie, W., Zhaojun, W., Meina, W., Yang, W., Zhang, J., & Qi, J. (2017) · BioMed Research International · doi:10.1155/2017/1238687 · Cited by 29

Management of Treatment-Resistant Obsessive-Compulsive Disorder

Gershkovich, M., Wheaton, M. G., & Simpson, H. B. (2017) · Current Treatment Options in Psychiatry · doi:10.1007/s40501-017-0127-8 · Cited by 29

Treatment Outcome and Predictors of Internet Guided Self-Help for Obsessive-Compulsive Disorder

Diefenbach, G. J., Wootton, B. M., Bragdon, L. B., Moshier, S. J., & Tolin, D. F. (2015) · Behavior Therapy · doi:10.1016/j.beth.2015.06.001 · Cited by 29

Physicians’ practice and familiarity with treatment for agitation associated with dementia in Israeli nursing homes

Cohen‐Mansfield, J., Juravel-Jaffe, A., Cohen, A., Rasooly, I., & Golander, H. (2012) · International Psychogeriatrics · doi:10.1017/s104161021200172x · Cited by 28

Obsessive–Compulsive Disorder in Children and Adolescents

Stiede, J. T., Spencer, S. D., Onyeka, O. “., Mangen, K. H., Church, M. J., Goodman, W. K., & Storch, E. A. (2023) · Annual Review of Clinical Psychology · doi:10.1146/annurev-clinpsy-080822-043910 · Cited by 27

Troubles anxieux résistants : revue des stratégies de traitements médicamenteux

Ammar, G., Naja, W., & Pélissolo, A. (2014) · L Encéphale · doi:10.1016/j.encep.2013.11.002 · Cited by 29

Integrating Exposure and Response Prevention With a Mobile App to Treat Obsessive-Compulsive Disorder: Feasibility, Acceptability, and Preliminary Effects

Gershkovich, M., Middleton, R., Hezel, D. M., Grimaldi, S. J., Renna, M. E., Basaraba, C. N., Patel, S. R., & Simpson, H. B. (2020) · Behavior Therapy · doi:10.1016/j.beth.2020.05.001 · Cited by 27

Functional connectivity changes and symptoms improvement after personalized, double-daily dosing, repetitive transcranial magnetic stimulation in obsessive-compulsive disorder: A pilot study

Mantovani, A., Neri, F., D’Urso, G., Mencarelli, L., Tatti, E., Momi, D., Menardi, A., Sprugnoli, G., Santarnecchi, E., & Rossi, S. (2020) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2020.10.030 · Cited by 28

Treatment of Patients With Obsessive-Compulsive Disorder

(2008) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9780890423370.151660 · Cited by 3

Chapter 52. Treatment of Obsessive-Compulsive Disorder

Kayser, R. R., & Simpson, H. B. (2024) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9781615375523.as52 · Cited by 1

Clinical practice guideline for obsessive-compulsive disorder

Matsunaga, H. (2019) · Asian College of Neuropsychopharmacology

Obsessive-Compulsive Disorder

GELLER, D. A. (2009) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9781585623921.md23 · Cited by 6

Obsessive-Compulsive Disorder (OCD)

(2015) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9781615370740.umd12 · Cited by 1